Recent

% | $
Quotes you view appear here for quick access.

Wi-Lan Inc. Message Board

ken_the_bum 45 posts  |  Last Activity: Aug 25, 2015 3:36 PM Member since: Aug 28, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Fire the CEO

    by goldinthelake Aug 25, 2015 3:21 PM
    ken_the_bum ken_the_bum Aug 25, 2015 3:36 PM Flag

    Why? He's been telling investors exactly what is going on. It's not his fault the market deduced that this company has no pipeline and is going nowhere. I'm listening to the same presentations and looking at the same data; and I get that this a screaming buy down here. I'm glad this stock is down here and has been going nowhere for now. It's called buying opportunity.

    -the bum

  • ken_the_bum by ken_the_bum Aug 25, 2015 8:27 AM Flag

    This week or early next week, we should get two upcoming event announcements from MEI:

    First, the 10K should be announced probably for Sept 8th (last year it was filed on the second Tuesday of Sept). Remember, MEI's fiscal year ends on June 30th so they will be filing an annual instead of a quarterly for the quarter ending June 30th.

    Second, Dr Gold has an institutional investor talk at the Wells Fargo Healthcare Conf on Sept 9-10.

    Both events will give Dr. Gold an opportunity to update investors a little more on the two Phase-II trials.

    -the bum

  • Reply to

    I’ll Ride it Out Here

    by ken_the_bum Aug 24, 2015 7:57 AM
    ken_the_bum ken_the_bum Aug 24, 2015 1:17 PM Flag

    If the overall market would stabilize soon, I think MEIP will rally before ASH. I know Dr Gold said he would be updating the Phase-II trials at ASH; but that immediately portends that he will have the data before then in order to submit any update at the conference. And if he has the data and the data continues to look as good as the last couple months, he must be talking to FDA to start planning a Phase-III. And it is that announcement of initiating discussions with FDA that will propel this stock up. Remember, this stock is $1.7 instead of $4 because the whole market has given up on Pracinostat. Any indication that Pracinostat is not dead and proceeding to the next trial level should start recovering this stock to $4.

    JMHO
    -the bum

  • ken_the_bum by ken_the_bum Aug 24, 2015 7:57 AM Flag

    I’m going to ride this market correction out between MEIP and cash. MEIP’s value is NOT based on revenues, which are susceptible to the overall economy and consumer demand. Also the company has plenty of cash and does not need to go to the finance well for a long time. Therefore, this company’s value is based mostly on the quality and timing of it’s R&D. And that R&D is shaping up pretty good right now.

    Historical charts show drug companies have fared better than the overall market during downturns – life-sustaining drugs are always considered an absolute consumer necessity. But with this downtrend looking awfully strong (especially in the foreign markets), there’s no way it’s not going to spill over into drug companies and MEIP, specifically. So I’m not sure how far down this whole thing goes, but I do believe I want to be right here in MEIP when it makes the turnaround.

    GLTA Longs,
    -the bum

  • ken_the_bum ken_the_bum Aug 21, 2015 3:56 PM Flag

    Ditto that for me.

    -the bum

  • Reply to

    looking for 3.90

    by deadoakontheground Aug 20, 2015 2:58 PM
    ken_the_bum ken_the_bum Aug 20, 2015 3:18 PM Flag

    Not today, but $3-$4 definitely on the horizon when they announce that they're proceeding with a Phase-III for Pracinostat. IMO today we're suffering from -300 Dow and -120 Nasdaq; and high beta stocks like MEIP get hit even harder. But better days will come, and Pracinostat news will ultimately drive this stock higher.

    -the bum

  • ken_the_bum by ken_the_bum Aug 20, 2015 8:40 AM Flag

    ...and just think what this could do on an up market day.

    -the bum

  • ken_the_bum ken_the_bum Aug 19, 2015 10:39 PM Flag

    Oops, make that 2.05 after hours, but the comment about the clown bashers still holds. It'll be interesting to see the open tomorrow. My guess is that MEIP drew a lot of attention today.

    -the bum

  • ken_the_bum ken_the_bum Aug 19, 2015 9:00 PM Flag

    MEIP gets a $2.15 tag afterhours; and the trend says tomorrow we might see above $2.00 during hours.
    ...... and ......
    this moj clown is still posting here.

    -the bum

  • Reply to

    NICE CLOSE HIGH OF DAY

    by beavertail_splash Aug 19, 2015 4:11 PM
    ken_the_bum ken_the_bum Aug 19, 2015 6:32 PM Flag

    Funny you should mention it. In my backyard today down here in Albuquerque, I had the pair of neighborhood roadrunners hunting out the lizards. They had a banquet. It was almost as fun as watching MEIP today..

    -the bum

  • ken_the_bum by ken_the_bum Aug 19, 2015 3:40 PM Flag

    You want to be here and hold until we get the news.

    GLTALongs

    -the bum

  • ken_the_bum by ken_the_bum Aug 19, 2015 3:33 PM Flag

    This uptrend started with the Webbush presentation last week and today it continues with volume (850K so far) .. and in a down market. What changed with Wedbush? IMO it was slide 10 that showed the terrific numbers for Pracinostat in the AML Phase-II trial:
    - CR rate increased from 20% to 42%
    - 60-day mortality dropped from 17% to 10%
    - One-years survival rate increased from 40% to 60%

    Suddenly, Pracinostat is looking more like the super-drug it originally started as. If so; this uptrend has a long, long way to go. IMO any announcement of Pracinostat Phase-III discussions with FDA can propel this stock to the $3 to $4 range.

    And that is why I’m holding on tight.

    -the bum

  • ken_the_bum by ken_the_bum Aug 19, 2015 10:47 AM Flag

    The buy/hold/sell story for this stock is quite simple: If you believe the data and interim results that Dr Gold is claiming for the two Phase-II Pracinostat trials, then this stock is way oversold and a correction should be forthcoming. If you choose to foolishly ignore the data and not believe the facts, then you probably need to short this and bash it all the time. Watch out, there are a few fools on this board.

    -the bum

  • ken_the_bum by ken_the_bum Aug 17, 2015 11:36 AM Flag

    Great to see MEIP run up with no news. It further confirms my take on this stock being way oversold based on the false assumption that their key drug is dead. As we all know, Pracinostat is not dead, but very much alive and so are many cancer patients taking this drug in two Phase-II trials.

    -the bum

  • ken_the_bum by ken_the_bum Aug 15, 2015 9:16 AM Flag

    This stock is news driven, and without news it seems to drift downward on low volume. So I look at upcoming events as possible news times for Dr. Gold to update investors on the status of Phase-II trials. Two such events are coming up within a month.

    First, the 10K should be filed probably on Sept 8th (the second Tuesday of Sept). MEI's fiscal year ends on June 30th so they will be filing an annual for the second quarter. Second, Dr Gold has another institutional investor talk at the Wells Fargo Healthcare Conf on Sept 9-10.

    Updating the AML (and MDS to a lesser extent) Phase-II Trials are big drivers for this stock. Investor know that positive results in these trials will lead to an announcement that MEI is planning a Phase III trial with Pracinostat. Last week, IMO market anticipation for the Wedbush conference was a big driver that took this stock up 20% from $1.5 to $1.8. I'm expecting at least the same in early September.

    -the bum

  • Reply to

    I Heard Pracinostat is Not Dead!

    by ken_the_bum Aug 12, 2015 3:05 AM
    ken_the_bum ken_the_bum Aug 12, 2015 4:30 PM Flag

    I like the way you say it.
    We'll see everybody here, come ASH in December.
    GLTA
    -the bum

  • Reply to

    I Heard Pracinostat is Not Dead!

    by ken_the_bum Aug 12, 2015 3:05 AM
    ken_the_bum ken_the_bum Aug 12, 2015 2:10 PM Flag

    I agree entirely -- ASH will be where most of the medical community learns of the benefits of Pracinostat. However the critical data will be obtained before December, so I think investors will be told of the progress of the Phase II Trials before ASH. For example, Dr. Gold has a presentation coming up at the Wells Fargo Healthcare Conf on Sept 9-10 and that would be an ideal time to make some comments on the progress. I could easily see some update of the MDS Phase-II Trial and maybe some refinement of the AML Phase II numbers in Slide 10 – especially a lower bounds for the overall survivability number. In yesterday’s Wedbush talk, Gold hinted pretty strongly that they have the necessary results and data to proceed with a Phase-III AML trial. I’m not sure at what point FDA Phase-III discussions must be reported by the company, but I am assuming that these will start long before ASH.

    As you noted, we’ll probably see the stock market anticipating a future Phase-III AML trial and this will evidenced in a continued uptrend in MEIP.

    JMHO
    -the bum

  • This stock dropped from $6 to below $2 back on Mar 23rd when the company announced they missed the primary endpoint on the Pracinostat-MDS Phase-II trial. The only way this stock could fall that far (even below cash value) is if the market was totally writing off Pracinostat.

    BUT….

    What I heard Dr. Gold say today is that Pracinostat is definitely NOT dead, and is alive and even doing better in the Pracinostat-AML Phase-II trial. The Wedbush talk is the first time that I’ve seen Slide 10, and the Pracinostat numbers for AML are approaching fantastic!
    - CR rate increased from 20% to 42%
    - 60-day mortality dropped from 17% to 10%
    - One-years survival rate increased from 40% to 60%
    - Overall survival is still TBD and increasing every month now
    Dr Gold even mentioned that there is some talk of starting the Phase III AML trial but he wanted to get the last bit of data from this trial first. Plus, he’s still following the MDS trial and there is definitely some clinical benefit for Pracinostat in that trial once the discontinuations from intolerance are neglected.

    So what I heard is that MEIP has the data it needs for a Phase III Pracinostat-AML trial and that data will help in designing a low-risk trial leading to Pracinostat success. It’s like the Phase-II MDS miss never happened. So let’s see if the market starts taking this stock back to $6.

    -the bum

  • Reply to

    $1.79 Now

    by ken_the_bum Aug 7, 2015 12:14 PM
    ken_the_bum ken_the_bum Aug 7, 2015 12:16 PM Flag

    Make that $1.81 and counting.

  • ken_the_bum by ken_the_bum Aug 7, 2015 12:14 PM Flag

    500K shares traded. Just a waiting for the news to show up -- and there IS some NEWS!

    -the bum

WILN
1.95+0.08(+4.28%)Aug 27 4:00 PMEDT